Talazoparib with enzalutamide for untreated hormone-sensitive metastatic prostate cancer with a homologous recombination repair mutation [ID6460]

  • Awaiting development
  • GID-TA11534
  • Expected publication date: TBC

31420-Talazoparib-Enzalutamide-for-Prostate-Cancer-V1.0-FEB2024-NON-CONF.pdf (nihr.ac.uk)